$ACAD Acadia Pharmaceuticals Inc (ACAD) Buy? Hold? Sell? Overall

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Time to Embrace Change: PhoenixAI Teams with Cloudera Mention the word 'partnership' in the tech space, and it's often as common as a cup of joe at dawn—but this one truly shakes things up. We're talking about PhoenixAI hitching its wagon to Cloudera's startup circus, a merging of fire and steel in AI-driven database management. With PhoenixAI strutting its stuff on the...

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Firstsource Solutions Limited (NSE: FSL) (BSE: 532809) made waves in the lending services sector when it was dubbed a 'Leader' in the 2024 Lending Services Operations PEAK Matrix Assessment by Everest Group. This assessment didn’t just throw around accolades; it rigorously evaluated thirty players in the field based on key metrics like market impact, strategic vision,...

Introduction to MoonLake Immunotherapeutics In the current stock market, dominated by discussions on interest rate cuts and the surge in artificial intelligence, the biotechnology sector often gets overshadowed. Nevertheless, for those investors looking to explore beyond the popular tech stocks, clinical-stage biotech companies offer remarkable event-driven returns...

Exploring Adalimumab Biosimilars in Modern Healthcare The field of adalimumab biosimilars is evolving rapidly, and recent insights reveal a fascinating picture. A study by Spherix Global Insights highlights that AbbVie’s Humira still holds a strong position in the market, even as biosimilars become more prevalent. Survey Findings on Healthcare Provider Attitudes A...

L'OCCITANE en Provence Unveils Unique Boutique on the Upper West Side L'OCCITANE en Provence has launched a distinctive new boutique that celebrates its roots in the vibrant Upper West Side. Located at 416 Columbus Ave, this boutique features a thoughtful redesign aimed at capturing the essence of Provence, a region in southeastern France that is deeply connected to the...

Many people begin the mortgage process by asking how much they can borrow. That feels logical, but it is usually the wrong starting point. A better question is how much you can carry comfortably without making the rest of your life feel tight every single month. Your mortgage payment is only one part of owning a home. You also need to cover property taxes, utilities, home...